Position in CVM
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,458
-$1,570 QoQ
Shares Held
766
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CVM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,458 | 766 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,028 | 766 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,148 | 777 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,863 | 814 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,419 | 6,175 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,470 | 3,678 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,228 | 20,028 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,071 | 19,028 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $35,620 | 18,650 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $47,849 | 17,592 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $19,464 | 15,573 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $28,323 | 11,753 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $26,747 | 11,530 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $27,080 | 11,524 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,585 | 11,517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,333 | 10,519 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $52,369 | 13,326 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $183,944 | 25,908 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $41,617 | 3,787 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $54,561 | 6,286 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $104,916 | 6,898 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $975,567 | 83,668 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,031,894 | 80,933 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,412,296 | 94,658 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $825,996 | 71,577 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||